BackAbbott Laboratories Overview
Abbott Laboratories

Abbott Laboratories Target Price

See Abbott Laboratories's analyst price targets ($120) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$109.35

Average Target Price

$123.1512.6% upside

13 analysts in the last 4 months

High: $134 | Low: $118

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-10-23UBS$1209.7% upsideOpen
2026-10-23Wells Fargo$1209.7% upsideOpen
2026-10-22Wells Fargo$1198.8% upsideOpen
2026-10-22Robert W. Baird$12312.5% upsideOpen
2026-10-22BTIGMarie Thibault$12514.3% upsideOpen
2026-10-16New Street$1209.7% upsideOpen
2026-10-06Barclays$1209.7% upsideOpen
2026-10-02Redburn PartnersEd Ridley-Day$12716.1% upsideOpen
2026-08-13Wolfe Research$13018.9% upsideOpen
2026-07-28UBSPatrick Wood$12514.3% upsideOpen
2026-07-20Benchmark Co.$1209.7% upsideOpen
2026-07-17Piper Sandler$1187.9% upsideOpen
2026-07-16BTIG$13422.5% upsideOpen
2026-07-06Evercore ISIVijay Kumar$1122.4% upsideOpen
2026-06-30Robert W. BairdDavid Rescott$12110.7% upsideOpen
2026-04-22Daiwa$9215.9% downsideOpen
2026-04-20BarclaysMatt Miksic$14330.8% upsideOpen
2026-04-17UBS$1155.2% upsideOpen
2026-04-17Stifel Nicolaus$1209.7% upsideOpen
2026-04-17Piper Sandler$1155.2% upsideOpen
2026-03-13New Street$14532.6% upsideOpen
2026-03-13UBSDanielle Antalffy$15844.5% upsideOpen
2026-02-02Barclays$14229.9% upsideOpen
2026-01-29Loop Capital MarketsIlya Zubkov$1209.7% upsideOpen
2026-01-23Evercore ISI$13826.2% upsideOpen
2026-01-23UBS$13220.7% upsideOpen
2026-01-23Mizuho SecuritiesAnthony Petrone$12514.3% upsideOpen
2026-01-23Piper Sandler$13523.5% upsideOpen
2026-01-23Bernstein$12514.3% upsideOpen
2026-01-23Wells FargoLarry Biegelsen$12211.6% upsideOpen
2026-01-09BernsteinLee Hambright$15440.8% upsideOpen
2026-01-09Goldman Sachs$15239% upsideOpen
2026-01-05Evercore ISI$14431.7% upsideOpen
2026-01-05Barclays$16954.5% upsideOpen
2025-12-22BTIGMarie Thibault$14532.6% upsideOpen
2025-11-21Tigress Financial$14532.6% upsideOpen
2025-10-17Barclays$16248.1% upsideOpen
2025-10-16Wells Fargo$14633.5% upsideOpen
2025-10-01Goldman Sachs$15743.6% upsideOpen
2025-07-15RBC CapitalShagun Singh$14734.4% upsideOpen
2025-04-15RBC CapitalShagun Singh$14028% upsideOpen
2025-01-08BernsteinLee Hambright$13523.5% upsideOpen
2024-10-17Piper SandlerAdam Maeder$13321.6% upsideOpen
2024-10-17BernsteinLee Hambright$13826.2% upsideOpen
2024-10-16JefferiesMatthew Taylor$12514.3% upsideOpen
2024-10-16Evercore ISIVijay Kumar$12817.1% upsideOpen
2024-10-16BTIGMarie Thibault$13927.1% upsideOpen
2024-10-08SusquehannaCharles Minervino$1209.7% upsideOpen
2024-10-08OppenheimerSuraj Kalia$13018.9% upsideOpen
2024-10-08RBC CapitalShagun Singh$13018.9% upsideOpen

Abbott Laboratories (ABT) FAQ

As of the most recent data, ABT shows a target price of $120. Scroll down for historical charts and peer comparison views.

If Abbott Laboratories moved to the average analyst target of $120, shares would be roughly 12.6% higher than $109.35. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Abbott Laboratories's earnings trajectory.

Besides this target price page, Stockcircle has Abbott Laboratories's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $120) with ownership activity and broader fundamentals.

Abbott Laboratories's target price is $120; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.